Sanofi

Paris, I0 · CIK 1121404 · 13F filing filed 2026-07-28

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Legal entitySANOFI (FR)

$534.0m reported value +59.0% vs Q1 2026

10positions

100.0%in top 10

2 new 0 added 0 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change
1	MEIRAGTX HLDGS PLC COM MGTX	MGTX	12,197,737	$164.8m30.86%	30.86%	Unchanged
2	INHIBRX BIOSCIENCES INC COM INBX	INBX	1,157,926	$109.7m20.54%	20.54%	Unchanged
3	NOVAVAX INC COM NEW NVAX	NVAX	6,880,481	$64.8m12.14%	12.14%	Unchanged
4	ANAPTYSBIO INC COM ANAB	ANAB	821,917	$55.5m10.39%	10.39%	Unchanged
5	ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX	ODTX	1,991,918	$37.3m6.98%	6.98%	New
6	AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB	AGMB	2,783,096	$36.1m6.76%	6.76%	Unchanged
7	MAPLIGHT THERAPEUTICS INC COM MPLT	MPLT	912,041	$32.7m6.12%	6.12%	Unchanged
8	FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX	TRAX	821,917	$16.5m3.10%	3.10%	New
9	IMMUNEERING CORP CLASS A COM IMRX	IMRX	2,708,559	$13.5m2.53%	2.53%	Unchanged
10	Q32 BIO INC COM QTTB	QTTB	244,083	$3.1m0.58%	0.58%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
ELEDON PHARMACEUTICALS INC ELDN	ELDN	814,980	$2.5m815.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
INNATE PHARMA S A IPHA · 13G · filed 2025-04-29	IPHA	9.1%	no change	13G	2025-04-29
AGOMAB THERAPEUTICS NV AGMB · 13G · filed 2026-05-06	AGMB	5.7%	new	13G	2026-05-06